MiR-21 confers resistance against CVB3-induced myocarditis by inhibiting PDCD4-mediated apoptosis
Coxsackievirus B3 type (CVB3), a small single-strand RNA virus belonging to the picornavirus family, is o en associated with heart disease and has been involved in up to 45% of the human cases of myocarditis or dilated cardiomyopathy [1] [2] [3] . Although much knowledge about CVB3 characteristics [4] [5] [6] , as well as the control measures [7] [8] [9] [10] , has been gained using murine CVB3-induced myocarditis models, there are still no e ective preventative or therapeutic strategies available in the clinic. e major reason for this is that the pathogenesis of viral myocarditis is not well understood; therefore, there is an urgent need to explore further mechanisms underlying the interaction of CVB3 with the host and to nd new potential targets for viral myocarditis therapy.
MicroRNAs (miRNAs) are a class of endogenous small single-strand non-coding RNAs that act as important posttranscriptional gene regulators. As part of a multi-protein complex known as RNA-induced silencing complex (RISC), miRNAs can silence the expression of multiple targets by partially complementing the 3' untranslated region (UTR) of target mRNA. Emerging evidence suggests that miRNAs are involved in many fundamental myocardial physiological and pathological processes [11] [12] [13] [14] by regulating apoptosis [15, 16] , vascularity [17] or cardiogenic di erentiation [18] . Altered microRNA expression patterns could be applied as a new biomarker and diagnostic tool [19] , and manipulating miRNAs might be an attractive therapeutic strategy [20, 21] , since they target genes speci cally and are easy to manipulate with speci c mimics or inhibitors. In support of this, recent studies have revealed miRNA-based treatments on pathological cardiac remodeling [22] , ischemic heart disease [15] and heart failure [23] .
Given the important role of miRNAs in myocardial physiopathology, myocardial miRNA expression patterns may change in CVB3-induced myocarditis. Identi cation of the key miRNA that speci cally impacts the severity and prognosis of viral myocarditis may provide not only a better understanding of the disease pathogenesis, but also clues to develop novel therapeutic regimes against infectious and in ammatory heart diseases.
Methods

Animals
Male BALB/c (H-2 d ) mice, 6 weeks of age, were bought from the Experimental Animal Center of Chinese Academy of Sciences (Shanghai, P. R. China) and bred in the speci c pathogen-free facility. All animal experiments were carried out in strict accordance with the recommendations in the Guide for the Care and Use of Medical Laboratory Animals (Ministry of Health, P. R. China, 1998). e protocol was approved by the Ethical Committee of Soochow University.
Virus
CVB3 (Nancy strain) was maintained by passage through HeLa cells (ATCC number: CCL-2). Virus titer was determined by a 50% tissue culture infectious dose (TCID50) assay on HeLa cell monolayer and calculated by the Reed-Muench method. Mice were infected by an intraperitoneal injection of 0.1 ml of PBS containing 10 3 TCID 50 CVB3.
In vi o delivery of pMDH-miR-21and pcDNA3.1-PDCD4
Plasmid pMDH-miR-21, encoding the murine precursor miR-21 and GFP protein, was a gi from Prof. Jinping Zhang at the Institutes of Biology and Medical Sciences, Soochow University, China. Mice were intraperitoneally infected with 10 3 TCID 50 CVB3 at day 0, and given 100 μg pMDH-miR-21 by hydrodynamic injection 1 day later. Myocarditis severity was evaluated at day 7 post-infection. For rescue of CVB3-induced programmed cell death 4 (PDCD4) down regulation, each mouse received 100 μg plasmid pcDNA3.1-PDCD4 kindly provided by Dr. Myung Haing Cho at Seoul National University, by hydrodynamic injection at 1 day post-infection. e other two groups were treated with empty vector pcDNA3.1 or PBS as controls. Day 7 post-infection, the apoptosis of heart cells were measured by Annexin-V (eBioscience) using a FACS calibur instrument (Becton Dickinson).
uantitation of viral load in heart tissues
Seven days a er CVB3 infection, hearts were collected and homogenized. Total RNA of the heart tissue was reversely transcribed to cDNA using a speci c primer (5'-CACCGGATGG CCAATCCA-3') and then the cDNA was subjected to SYBR green real-time PCR using CVB3-speci c primers (5'-ATCAA GTTGCGTGCTGTG-3' and 5'-TGCGAAATGAAAGGA GTGT-3'). Expression of the virus RNA load was normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression.
Histopathological analysis and myocarditis scoring
Hearts were collected from infected mice at day 7, xed in 10% bu ered formalin solution and embedded in para n. Sections 5 μm thick were cut and stained with hematoxylin and eosin. e extent of myocardial lesions was quanti ed and scored as previously described [24] . Pathological scores were de ned based on the following semi-quantitative scale: 0, no in ammatory in ltrates; 1, one to ve in ammatory cells in each detected microscopy eld and the total in ammatory in ltrate area was less than 5% of the eld; 2, more than ve in ammatory cells in each detected microscopy eld or the total inammatory in ltrate area was between 5% and 20%; 3, inammatory in ltrate area was more than 20% and there was no necrosis; 4, di use in ammatory in ltrates with necrosis. Analysis was performed double-blind by a trained pathologist.
Real-time PCR
e total RNA of heart tissues was extracted with miRNeasy MiniKit (Qiagen) and then reverse transcribed with miRNAspeci c stem-loop RT primers (Table 1) into cDNA. Real-time primers for microRNAs (miR-21, -29b, -92a, -126-5p, -199a, -210, -320, -499) and house-keeping gene GADPH were designed and sequences were shown in Table 2 . Gene expressions were detected by SYBR green real-time PCR and quanti cation of data was analyzed using the 2 -ΔΔCt method.
FACS analysis of annexin-V + myocardiocytes
Hearts were collected from CVB3-infected mice at day 7 and a single-cell suspension of myocardiocytes was prepared. Following staining with uorescein-isothiocyanate (FITC) conjugated annexin-V, cells were subjected to a ow cytometry assay using FACS calibur and Cell uest so ware (Becton Dickinson).
Immunohistochemistry
To evaluate the myocardial expression of PDCD4, sections of heart tissue were heated by microwave in 0.01% citrate bu er and treated with 3% H2O2 for 15 min to inhibit endogenous peroxidase activity. A er blocking with 3% BSA-PBS for 30 min, sections were incubated with the rat anti-mouse PDCD4 antibody (Cell Signaling Technology) at 4°C overnight, then with biotinylated rabbit anti-rat antibody (Dako) and a streptavidin-peroxidase-based detection kit (Dako) before revealing with diaminobenzidine/hydrogen peroxidase substrate and hematoxylin counterstaining. 
Results
Myocardial miR-21 expression was dramatically reduced in CVB3-induced myocarditis
Mounting evidence shows that miRNAs play an important role in infectious [25] and myocardial diseases [11] and we propose that miRNAs may participate in the development of CVB3-induced myocarditis. To address this hypothesis, the expression of several previously reported myocardium-associated miRNAs were determined in CVB3-infected heart tissues. As shown in Fig. 1 , expression of three miRNAs (miR-21, -199a, -320) was downregulated in CVB3-infected mice compared with naive mice, with the most dramatic decline in miR-21 (about 3.6 fold). Meanwhile, the expression of ve miRNAs (miR-29b, -499, -210, -126-5p, -92a) was increased in CVB3-infected heart tissues.
Considering that the downregulated miRNA may exert protective e ects on CVB3-induced myocarditis, the myocardial miR-21 expression levels in mice with mild and severe viral myocarditis were compared. It was found that miR-21 expression was much lower in mice with severe myocarditis than those with benign myocarditis (Fig. 2) , suggesting that miR-21 may take a protective part in CVB3-induced myocarditis.
MiR-21 treatment signi cantly alleviated CVB3-induced myocarditis
To clarify the role of miR-21 in CVB3-induced myocarditis, mice were given a hydrodynamic injection of pMDH-miR-21 encoding the miR-21 precursor at day 1 postinfection. By day 7, there was a 2.3-fold increase in expression in the pMDHmiR-21 injection group (Fig. 3A) , con rming successful in vi o delivery of miR-21. In contrast to the dramatic drop in body weight in control and empty vector pMDH-treated mice, a slight increase in myocarditis was shown in pMDH-miR-21-treated mice (Fig.3B) , accompanied by reduced myocardial in ammation (Fig.3C) , lower myocarditis score (Fig.3D) , improved survival rate and increased heart viral load ( Fig.3E and  3F ). ese data indicated that miR-21 administration substantially improved CVB3-induced myocarditis despite of promot- Mice (n=5 per group) were injected with pMDH-miR-21 at day 1 postinfection, and myocardial miR-21 expression was detected by real-time PCR on day 7 (A). Meanwhile, myocarditis severity was evaluated on day 7 by indices of body weight loss (B), myocardial pathological observation (C) and myocarditis score (D) as well as survival rate (E). Heart viral load was also determined on day 7 (F). For survival rate evaluation, each group contained ten mice. e experiments were repeated three times with similar results. *, P<0.05, **, P<0.01, ***, P<0.001.
ing virus replication.
MiR-21 treatment robustly decreased CVB3-induced myocardial apoptosis
Previous studies have suggested that miR-21 could in uence disease by regulating cell apoptosis, miR-21's e ect on CVB3-induced myocardial apoptosis was analyzed using ow cytometry. ere was a 2-fold decrease in the percentage of apoptotic myocardiocytes in pMDH-miR-21 treated group compared with that of the control group (52.11% and 21.03%, respectively, Fig. 4A and 4B ), indicating that miR-21 functioned as an anti-apoptotic factor of myocardiocytes in CVB3 infection. As expected, no obvious change in myocardial apoptosis was shown between the pMDH treated and control mice.
MiR-21 performed its anti-apoptotic e ect on CVB3-induced myocarditis by targeting PDCD4
PDCD4 plays an important role in regulating cell apoptosis and is a direct target gene of miR-21. To verify whether PDCD4 is involved in CVB3-induced myocardial apoptosis, its expression in CVB3-infected heart tissues was investigated using immunochemistry staining assays. As shown in Fig. 5A , CVB3 infection signi cantly elevated myocardial PDCD4 expression, while this increase could be robustly abolished by pMDH-miR-21 administration evidenced by the obviously fewer PDCD4 positive cells in hearts. In addition, when PDCD4 expression in CVB3-infected mice was rescued by pcDNA3.1-PDCD4 administration, the apoptotic myocardiocyte frequency was signi cantly increased (67.7%) compared with mice receiving empty vector pcDNA3.1 (44.1%) or no treatment (41.2%) (Fig.5B) , indicating that miR-21 exerted its anti-apoptotic e ect on viral myocarditis by reducing target PDCD4 expression.
Discussion
In this study, the altered myocardial expression of several myocardium-associated miRNAs in CVB3-induced myocarditis is described. ree downregulated (miR-21, -199a, -320) and ve upregulated miRNAs (miR-29b, -499, -210, -126-5p, -92a) were identi ed, suggesting that miRNAs could be modulated by CVB3 infection and may participate in the pathogene- sis of viral myocarditis. Among these miRNAs, miR-21 has been proven to play a role in infectious [26] and in ammatory heart disease [27] and was the miRNA whose expression dropped most signi cantly. In addition, the altered miR-21 expression was more likely due to CVB3-induced myocarditis because no signi cant reduction in miR-21 was seen at the early stages of infection, with the maximum viral replication (day 3), but was observed at the late infection stage, with the maximum myocardial in ammation (day 7). For this reason, the next steps in the study focused on miR-21. Myocardial miR-21 expression was signi cantly reduced in CVB3-infected mice, and the more pronounced the myocarditis was, the greater the decrease in myocardial miR-21 levels was, indicating a negative correlation between miR-21 expression and myocarditis severity (Fig.2) . To further evaluate the role of miR-21 in CVB3-induced myocarditis, pMDH-miR-21 was administrated to the infected mice and led to signi cantly alleviated myocarditis. It is known that apoptosis and necrosis both contribute to the cell death in myocarditis [3] ; however, a change in degree of necrosis was not seen with miR-21 levels over the course of infection indicating the protection role of miR-21 in CVB3-induced myocarditis might depend on regulation of apoptosis. It has been reported that CVB3 infection can dramatically induce myocardial apoptosis via death receptor-mediated and mitochondrial-mediated signaling pathways [28] [29] [30] , and apoptosis is also o en evidenced in patients of acute myocarditis [31] . Additionally, anti-apoptosis approaches signi cantly improved CVB3-induced heart injury [32, 33] , further con rming the pathological role of apoptosis in the acute myocarditis. Our results were in line with previous studies that show miR-21 targeting PDCD4 to produce antiapoptotic e ect; however, these studies are mainly focused on the elds of tumor [34] [35] [36] and vascular diseases [37, 38] . Only a few studies report that miR-21 exerts an anti-apoptotic e ect by targeting PDCD4 in heart diseases. Furthermore, all of these studies report a role of miR-21 in non-infectious heart diseases, such as myocardial ischemia-reperfusion injury [39, 40] and H2O2-induced myocardial injury [41] . In the present study, CVB3 infection signi cantly reduced the expression of myocardial miR-21, which protected infected myocardiocytes from apoptosis. is is the rst time miR-21 has been shown to perform its anti-apoptotic e ects by targeting PDCD4 in viral myocarditis and thereby extending its anti-apoptotic e ects to the eld of infectious heart diseases. Nevertheless, the possibility that miR-21 may also perform its protective e ect on CVB3-induced myocarditis by other pathways like promoting myocardiocyte outgrowth [42] and upregulating important cardioprotective proteins [43] cannot be excluded.
MiRNAs exert their biological functions by regulating their multiple target genes. It has been reported that the tumor suppressor PDCD4 is an important functional target of miR-21 [44] and participates in the apoptosis of many cell types [45, 46] . Recently Cheng et al. [41] reported that miR-21 suppressed the H2O2-induced myocardial apoptosis via targeting PDCD4. miR-21 may, therefore, perform an anti-apoptotic role in viral myocarditis by inhibiting PDCD4. As illustrated by the immunohistochemistry results, the number of PDCD4-positive myocardiocytes was signi cantly reduced in mice receiving pMDH-miR-21, indicating that miR-21 e ciently inhibited its target PDCD4 expression and decreased the subsequent myocardial apoptosis. Other apoptosis-associated targets of miR-21, such as tumor suppressor phosphatase and tensin homolog (PTEN) [47] and Fas ligand and metalloproteinase inhibitor 3 (TIMP3) [48] , may also participate in CVB3-induced myocarditis, and further studies need to be conducted for validation.
In this study, myocardial miR-21 expression was signicantly decreased in CVB3-induced myocarditis and negatively associated with the disease severity. MiR-21 treatment could signi cantly relieve viral myocarditis by inhibiting PDCD4-mediated myocardial apoptosis. is study may help us better understand the pathogenesis of myocarditis and represent a new therapeutic strategy against CVB3-induced myocarditis.
